Adipocytokines and Insulin Resistance across Various Degrees of Glucose Tolerance in Pregnancy

Abstract

OBJECTIVE: Gestational diabetes mellitus is characterized by progressive insulin resistance. Adipocytokines are thought to be associated with insulin resistance. This cross-sectional study evaluated the associations between serum concentrations of several adipocytokines and insulin resistance at different stages of glucose tolerance in pregnancy, using the homeostasis model assessment of insulin resistance (HOMA-IR) as a reference. METHODS: According to oral glucose tolerance test results, 74 pregnant women were divided into three groups: normal glucose tolerance (n = 25); intermediate glucose tolerance (n = 19); gestational diabetes mellitus (n = 30). Adiponectin, leptin, resistin, visfatin and retinol-binding protein 4 (RBP4) concentrations were measured using enzyme-linked immunosorbent assays. RESULTS: Groups were comparable regarding age, week of gestation and body mass index before gestation. There were statistically significant between-group differences in HOMA-IR, but no significant differences regarding serum adipocytokine concentrations. CONCLUSIONS: Adiponectin, leptin, resistin, visfatin and RBP4 were not associated with the degree of glucose tolerance in pregnancy. Concentrations of these adipocytokines are not sufficiently sensitive to replace HOMA-IR in pregnancy.

Keywords

Diabetes Pregnancy Insulin Resistance Kadiponectin Leptin Rresistin Visfatin Retinol-Binding Protein 4

References

Jovanovic

Pettitt

: Gestational diabetes mellitus. JAMA 2001; 28: 2516–2518.

DeFronzo

Tobin

Andres

: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–E223.

Matthews

Hosker

Rudenski

: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

Bonora

Targher

Alberiche

: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63.

Retnakaran

Connelly

: Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 2010; 53: 268–276.

Atègbo

J-M

Grissa

Yessoufou

: Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91: 4137–4143.

Cortelazzi

Corbetta

Ronzoni

: Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 2007; 66: 447–453.

Vitoratos

Deliveliotou

Vlahos

: Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol Endocrinol 2008; 24: 614–619.

Chen

Fang

Chai

: Serum resistin in gestational diabetes mellitus and early postpartum. Clin Endocrinol (Oxf) 2007; 67: 208–211.

10.

Kuzmicki

Telejko

Szamatowicz

: High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009; 25: 258–263.

11.

Megia

Vendrell

Gutierrez

: Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol 2008; 158: 173–178.

12.

Vitoratos

Dimitrakaki

Vlahos

: Maternal and umbilical resistin levels do not correlate with infant birth weight either in normal pregnancies and or in pregnancies complicated with gestational diabetes. J Matern Fetal Neonatal Med 2010; 23: 1019–1023.

13.

Krzyzanowska

Krugluger

Mittermayer

: Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 2006; 110: 605–609.

14.

Lewandowski

Stojanovic

Press

: Elevated serum levels of visfatin in gestational diabetes: A comparative study across various degrees of glucose tolerance. Diabetologia 2007; 50: 1033–1037.

15.

Akturk

Altinova

Mert

: Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. J Endocrinol Invest 2008; 31: 610–613.

16.

Chan

Chen

Lee

: Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Invest 2006; 13: 364–367.

17.

Szamatowicz

Kuźmicki

Telejko

: Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes. Ginekol Pol 2009; 80: 14–18.

18.

Kautzky-Willer

Pacini

Tura

: Increased plasma leptin in gestational diabetes. Diabetologia 2001; 44: 164–172.

19.

Lewandowski

Stojanovic

Bienkiewicz

: Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol 2008; 24: 300–305.

20.

Hong

Yan

: Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus. Diabetes Metab 2010; 36: 470–475.

21.

Krzyzanowska

Zemany

Krugluger

: Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia 2008; 51: 1115–1122.

22.

Metzger

Coustan

: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998; 21 (suppl 2): B161–B167.

23.

R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2008. ISBN 3–900051-07–0 (available at: http://www.r-project.org).

24.

Weyer

Funahashi

Tanaka

: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–1935.